Karin Mayer

2.7k total citations
39 papers, 1.2k citations indexed

About

Karin Mayer is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Karin Mayer has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Hematology and 15 papers in Epidemiology. Recurrent topics in Karin Mayer's work include Acute Myeloid Leukemia Research (13 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Research Studies (7 papers). Karin Mayer is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Neuroendocrine Tumor Research Advances (8 papers) and Lung Cancer Research Studies (7 papers). Karin Mayer collaborates with scholars based in Germany, United States and Malaysia. Karin Mayer's co-authors include Samer Ezziddin, Amir Sabet, Hans‐Jürgen Biersack, Hojjat Ahmadzadehfar, Torjan Haslerud, Peter Brossart, Aristoteles Giagounidis, Uwe Platzbecker, Thomas Wolff and Philipp Kiewe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Karin Mayer

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Mayer Germany	17	570	561	362	354	245	39	1.2k
Karoline Ehlert Germany	19	253 0.4×	296 0.5×	311 0.9×	241 0.7×	83 0.3×	60	1.1k
Carlos Grande Spain	18	96 0.2×	622 1.1×	151 0.4×	371 1.0×	206 0.8×	82	1.4k
Jong Jin Seo South Korea	24	143 0.3×	291 0.5×	132 0.4×	655 1.9×	213 0.9×	110	1.5k
Wilhelm Woessmann Germany	26	104 0.2×	740 1.3×	450 1.2×	417 1.2×	314 1.3×	65	2.0k
Matthew Carabasi United States	15	501 0.9×	910 1.6×	72 0.2×	682 1.9×	119 0.5×	47	1.7k
Chirayu Auewarakul Thailand	18	173 0.3×	151 0.3×	73 0.2×	343 1.0×	210 0.9×	63	1.0k
Gwynn D. Long United States	23	214 0.4×	759 1.4×	198 0.5×	1.2k 3.3×	403 1.6×	83	2.0k
Viviane Dubruille France	20	140 0.2×	405 0.7×	62 0.2×	872 2.5×	605 2.5×	68	1.4k
Catherine Paillard France	19	93 0.2×	237 0.4×	183 0.5×	390 1.1×	150 0.6×	68	973
Anita Gustavsson Sweden	19	243 0.4×	307 0.5×	114 0.3×	144 0.4×	70 0.3×	35	978

Countries citing papers authored by Karin Mayer

Since Specialization

Citations

This map shows the geographic impact of Karin Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Mayer more than expected).

Fields of papers citing papers by Karin Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Mayer. The network helps show where Karin Mayer may publish in the future.

Co-authorship network of co-authors of Karin Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Mayer. A scholar is included among the top collaborators of Karin Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Mayer. Karin Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mayer, Karin, et al.. (2023). Treatment of acute myeloid leukaemia in older patients – scope of intensive therapy? – A retrospective analysis. Hematology. 28(1). 2212536–2212536. 1 indexed citations

Claßen, Annika Y., Larissa Henze, Marie von Lilienfeld‐Toal, et al.. (2021). Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). Annals of Hematology. 100(6). 1603–1620. 46 indexed citations

Krzykalla, Julia, Silke Kapp‐Schwoerer, Verena I. Gaidzik, et al.. (2021). Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with <i>nucleophosmin1</i>-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin. Haematologica. 106(11). 2986–2989. 5 indexed citations

Mayer, Karin, et al.. (2021). Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single-Center Analysis. Oncology Research and Treatment. 44(10). 538–546. 8 indexed citations

Yordanova, Anna, Karin Mayer, Peter Brossart, et al.. (2018). The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy. Clinical Cancer Research. 24(19). 4672–4679. 58 indexed citations

Rieger, C., Blasius Liss, Sibylle C. Mellinghoff, et al.. (2018). Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Annals of Oncology. 29(6). 1354–1365. 56 indexed citations

Platzbecker, Uwe, Ulrich Germing, Katharina S. Götze, et al.. (2017). Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study. The Lancet Oncology. 18(10). 1338–1347. 204 indexed citations

Yordanova, Anna, Karin Mayer, Peter Brossart, et al.. (2017). Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour. European Journal of Nuclear Medicine and Molecular Imaging. 44(7). 1207–1214. 57 indexed citations

Lilienfeld‐Toal, Marie von, Annemarie Berger, Maximilian Christopeit, et al.. (2016). Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. European Journal of Cancer. 67. 200–212. 50 indexed citations

10.

Hahn‐Ast, Corinna, Karin Mayer, Markus Ruhnke, et al.. (2016). Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia. Annals of Hematology. 95(6). 1001–1009. 6 indexed citations

11.

Yordanova, Anna, Karin Mayer, Markus Essler, & Hojjat Ahmadzadehfar. (2016). Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis. Clinical Nuclear Medicine. 41(12). 977–979. 5 indexed citations

12.

Giagounidis, Aristoteles, Uwe Platzbecker, Ulrich Germing, et al.. (2015). Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study. Blood. 126(23). 92–92. 22 indexed citations

13.

Sabet, Amir, Torjan Haslerud, Amin Sabet, et al.. (2015). Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine. European Journal of Nuclear Medicine and Molecular Imaging. 42(8). 1238–1246. 82 indexed citations

14.

Platzbecker, Uwe, Ulrich Germing, Aristoteles Giagounidis, et al.. (2015). Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study. Blood. 126(23). 2862–2862. 5 indexed citations

15.

Sabet, Amir, Carsten H. Meyer, Amin Sabet, et al.. (2014). Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 370–376. 36 indexed citations

16.

Ezziddin, Samer, Torjan Haslerud, Karin Mayer, et al.. (2014). Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 41(5). 925–933. 148 indexed citations

17.

Sabet, Amir, Ulrich‐Frank Pape, Hojjat Ahmadzadehfar, et al.. (2013). Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-Octreotate. Journal of Nuclear Medicine. 54(11). 1857–1861. 124 indexed citations

18.

Heine, Annkristin, et al.. (2013). Advances in Immunotherapy of Chronic Myeloid Leukemia CML. Current Cancer Drug Targets. 13(7). 768–774. 15 indexed citations

19.

Stuplich, Moritz, Karin Mayer, Young Kim, et al.. (2011). Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma. Acta Haematologica. 127(2). 93–95. 6 indexed citations

20.

Wenz, Frederik, et al.. (1999). Radiochemotherapy with paclitaxel: Synchronization effects and the role of p53. Strahlentherapie und Onkologie. 175(S3). 2–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact